Form 4 holding
VP, Clinical Affairs
TransMedics Group, Inc.
- Security class
- Common Stock
- Shares / value
- 5,685
- Estimated value
- $512,162
- Report date
- 20 Feb 2023
- Price
- $90.09
- Ownership
- Direct
Laura Damme - VP, Clinical Affairs at TransMedics Group, Inc.
Issuer-level insider activity
- Role
- VP, Clinical Affairs
- Issuer ticker
- TMDX on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Laura Damme since 10 Sep 2025
Reported holdings for Laura Damme in TransMedics Group, Inc.
Form 4 holding
VP, Clinical Affairs
TransMedics Group, Inc.
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 8,705
- Estimated value
- Report date
- 20 Feb 2023
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Laura Damme in TransMedics Group, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.